Does DIHYDROERGOTAMINE Cause Neovascularisation? 59 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Neovascularisation have been filed in association with DIHYDROERGOTAMINE (Dihydroergotamine Mesylate). This represents 5.6% of all adverse event reports for DIHYDROERGOTAMINE.
59
Reports of Neovascularisation with DIHYDROERGOTAMINE
5.6%
of all DIHYDROERGOTAMINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Neovascularisation From DIHYDROERGOTAMINE?
Of the 59 reports.
Is Neovascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIHYDROERGOTAMINE. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does DIHYDROERGOTAMINE Cause?
Drug ineffective (565)
Nausea (350)
Off label use (343)
Hyperhidrosis (314)
Nightmare (313)
Sedation (313)
Product use in unapproved indication (252)
Nephrolithiasis (230)
Migraine (100)
Treatment failure (99)
What Other Drugs Cause Neovascularisation?
LAMOTRIGINE (62)
PREDNISONE (60)
PROPRANOLOL (60)
AMLODIPINE (59)
ATENOLOL (59)
GABAPENTIN (59)
METOCLOPRAMIDE (59)
NADOLOL (59)
NAPROXEN (59)
NARATRIPTAN (59)
Which DIHYDROERGOTAMINE Alternatives Have Lower Neovascularisation Risk?
DIHYDROERGOTAMINE vs DILANTIN
DIHYDROERGOTAMINE vs DILANTIN-125
DIHYDROERGOTAMINE vs DILAUDID
DIHYDROERGOTAMINE vs DILTIAZEM
DIHYDROERGOTAMINE vs DIMENHYDRINATE